JRS Pharma

	The development of co-processed, multifunctional excipients has enabled formulators to address multiple challenges with a single excipient, resulting in enhanced production and better finished product quality. In this webcast, learn about how the evolution from traditional powdered cellulose to microcrystalline cellulose to a new generation of co-processed high functionality excipients can benefit tableting processes including continuous manufacturing applications.

		How the development of microcrystalline cellulose from powdered cellulose results in different grades to address a wider range of formulation challenges

		How the application of co-processing techniques combined mono-functional excipients to create high-functionality excipients with multiple benefits and added value

		How further development from binary co-processed excipients to multi-component composites provides the user with ingredients that can reduce process complexity and enhance product quality in continuous manufacturing applications

	Scientists, managers, research and development, sales, quality, and procurement professionals at pharmaceutical, nutritional, and contract development and manufacturing organizations

Tony E. Carpanzano, BS, RPh, Director of R&D, JRS Pharma

 Wednesday, Sept. 25, 2019 at 10am EDT | 3pm BST | 4pm CEST

	On demand available after airing until Sept. 25, 2020

Webcasts

From functional fillers to high functionality excipients, discover the evolution of cellulose in tableting technology. 
Live: Wednesday, Sept. 25, 2019 at 10am EDT | 3pm BST | 4pm CEST
On demand available after airing until Sept. 25, 2020
Register free



JRS Pharma

Articles